AbCellera Biologics's market cap is currently $989.84M. The company's EPS TTM is €; its P/E ratio is ―; AbCellera Biologics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is €-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 38.02M	$ 485.42M	$ 375.20M	$ 233.16M	$ 11.61M
Gross Profit	$ 38.02M	$ 418.99M	$ 329.69M	$ 206.01M	$ 1.50M
Operating Income	$ -237.21M	$ 216.51M	$ 204.41M	$ 156.03M	$ -4.12M
EBITDA	$ -192.16M	$ 272.20M	$ 241.62M	$ 169.62M	$ -397.42K
Net Income	$ -146.40M	$ 158.52M	$ 153.46M	$ 118.92M	$ -2.42M
Balance Sheet
Cash & Short-Term Investments	$ 760.59M	$ 886.49M	$ 722.98M	$ 594.12M	$ 7.55M
Total Assets	$ 1.49B	$ 1.54B	$ 1.32B	$ 1.01B	$ 23.49M
Total Debt	$ 77.38M	$ 82.26M	$ 36.41M	$ 6.10M	$ 6.89M
Net Debt	$ -55.94M	$ -304.28M	$ -439.73M	$ -588.01M	$ -661.93K
Total Liabilities	$ 335.78M	$ 307.63M	$ 292.84M	$ 175.03M	$ 13.24M
Stockholders' Equity	$ 1.15B	$ 1.23B	$ 1.03B	$ 830.51M	$ 10.25M
Cash Flow
Free Cash Flow	$ -121.38M	$ 204.70M	$ 186.13M	$ 8.02M	$ -1.30M
Operating Cash Flow	$ -43.88M	$ 277.36M	$ 244.58M	$ 22.69M	$ 2.69M
Investing Cash Flow	$ -221.11M	$ -352.63M	$ -332.25M	$ -119.78M	$ -5.78M
Financing Cash Flow	$ 10.36M	$ -1.63M	$ -3.89M	$ 683.65M	$ 194.83K

Currency in USD

AbCellera Biologics Earnings and Revenue History

Income Statement >

AbCellera Biologics Debt to Assets

Balance Sheet >

AbCellera Biologics Cash Flow

Cash Flow >

AbCellera Biologics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing